Walker David D, Babu Seilesh
Department of Neurotology, Michigan Ear Institute, Farmington Hills, Michigan, United States.
J Neurol Surg B Skull Base. 2019 Apr;80(2):209-213. doi: 10.1055/s-0039-1679890. Epub 2019 Feb 14.
Despite numerous advancements in the treatment of skull base tumors, the management of jugular paragangliomas remains controversial and nuanced. Contemporary treatment objectives focus not only on achieving durable tumor control but also on maximizing post-treatment quality of life. While this philosophy places appropriate attention on limiting cranial neuropathies, less discussed morbidities such as hearing loss can have a profound impact on quality of life outcomes. The objective of this retrospective review is to provide a comprehensive review of hearing outcomes following the treatment of tympanojugular paragangliomas. A particular focus is placed on the variable audiologic outcomes as it relates to disease pathology, extent of disease, as well as chosen treatment modality. This review underscores the importance of considering treatment-related effects on hearing.
尽管在颅底肿瘤治疗方面取得了诸多进展,但颈静脉球瘤的管理仍存在争议且较为微妙。当代治疗目标不仅注重实现持久的肿瘤控制,还致力于使治疗后的生活质量最大化。虽然这种理念适当关注了限制颅神经病变,但诸如听力损失等较少讨论的发病率可能对生活质量结果产生深远影响。本回顾性研究的目的是全面回顾鼓室颈静脉球瘤治疗后的听力结果。特别关注与疾病病理、疾病范围以及所选治疗方式相关的可变听力结果。本综述强调了考虑治疗对听力相关影响的重要性。